Clinical Trials Sponsored by Ovation Research Group

Total 1442 results

Versartis Inc.
Premier Research Group plc

Completed

Versartis International Trial in Adults With Long-Acting Growth Hormone (VITAL)

Adult Growth Hormone Deficiency

United States, Australia, Germany, United Kingdom
Ottawa Hospital Research Institute
Canadian Cancer Trials Group

Completed

Exercise in Men Receiving Radiation Therapy for Prostate Cancer.

Prostatic Neoplasms

Canada
SOLTI Breast Cancer Research Group
Pierre Fabre Laboratories

Completed

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

Breast Cancer

Spain
Teikoku Pharma USA, Inc.
Premier Research Group plc

Completed

Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy (DMTS)

Pain, Postoperative

Australia
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma

Ovarian Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer

Non-small-cell Lung Cancer

Greece
University of Calgary
Foothills Interventional Cardiology Research Group

Completed

Post Conditioning in PCI for Acute ST Elevation Myocardial Infarction

Myocardial Infarction

Canada
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer

Breast Cancer

Greece
Cancer Biotherapy Research Group

Unknown

Biological Therapy in Previously Treated Patients With Non-small Cell Lung Cancer

Lung Cancer

United States
Cancer Therapeutics Research Group
National Cancer Institute (NCI)

Completed

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer

Australia, Singapore, Hong Kong
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer

Non-Small-Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Topotecan in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Carcinoma

Ovarian Cancer

Greece
Hoag Memorial Hospital Presbyterian
Cancer Biotherapy Research Group

Completed

Tumor Cell Vaccine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients

Gastric Cancer

Greece
Washington Neuropsychology Research Group
Genzyme, a Sanofi Company

Unknown

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

Relapsing Remitting Multiple Sclerosis

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Non-Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Greece
Trans Tasman Radiation Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical... and other collaborators

Active, not recruiting

Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast (DCIS)

Carcinoma, Ductal, Breast

United Kingdom, Netherlands, Ireland, Switzerland, Australia, Singapore, New Zealand, Belgium, Canada, Italy, France
European Organisation for Research and Treatment...
Breast International Group; Menarini Group

Recruiting

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) (TREAT ctDNA)

Stage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer

Belgium, Italy, Ireland, France, Germany
European Organisation for Research and Treatment...
Swiss Group for Clinical Cancer Research; Swedish Breast Cancer Group; Anglo...

Completed

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Breast Cancer

France, Switzerland, Poland, Sweden, Belgium, Netherlands, United Kingdom, Portugal, Slovenia
Amsterdam UMC, location VUmc
University Ghent; Reade Rheumatology Research Institute

Recruiting

Effect of Functional Power Training on Calf Muscle Length and Strength in Children With Spastic Paresis (MegaMuscle)

Cerebral Palsy, Spastic

Netherlands
Liz-Anne Lewsley
Ovarian Cancer Action

Recruiting

Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma (BriTROC-2)

Ovarian Cancer | Fallopian Tube Cancer | BRCA1 Mutation | BRCA2 Mutation | High Grade Serous Carcinoma | Primary Peritoneal Carcinoma | Carcinosarcoma, Ovarian

United Kingdom
NYU Langone Health
Lynne Cohen Foundation for Ovarian Cancer Research

Completed

Cancer Screening and Prevention Program for High Risk Women

Breast Cancer | Ovarian Cancer

United States
Centre Hospitalier Universitaire Vaudois
Agroscope Liebefeld-Posieux Research Station ALP

Completed

Effects of a Probiotics on the Health of Normal Young Males (FFF)

Inflammation | Dyslipidemia

Switzerland
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
SOLTI Breast Cancer Research Group
Roche Pharma AG

Recruiting

Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients (IPATHER)

Metastatic Breast Cancer

Spain
Spanish Oncology Genito-Urinary Group
Adknoma Health Research

Completed

SOGUG-AVELUMAB_RWD (SOGUG)

Metastatic Urothelial Carcinoma

Spain
Canadian Cancer Trials Group
Ottawa Hospital Research Institute

Active, not recruiting

MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours

Advanced/Metastatic Solid Tumours

Canada
SOLTI Breast Cancer Research Group
Daiichi Sankyo, Inc.

Active, not recruiting

NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial (VALENTINE)

Breast Cancer

Spain
Versartis Inc.
Premier Research Group plc

Terminated

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Adult Growth Hormone Deficiency (AGHD)
Spanish Breast Cancer Research Group
Bristol-Myers Squibb

Completed

Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients

Metastatic Breast Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

Breast Cancer

Spain
SOLTI Breast Cancer Research Group
Radius Health, Inc.

Completed

Elacestrant in Preoperative Setting, a Window of Opportunity Study (ELIPSE)

Breast Cancer | Hormone Receptor Positive Breast Carcinoma

Spain
Aptinyx
Massachusetts General Hospital; Premier Research Group plc

Completed

Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder

Post-Traumatic Stress Disorder

United States
Spanish Breast Cancer Research Group
Hoffmann-La Roche

Terminated

Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab

Breast Cancer

Spain
Kantonsspital Graubuenden
Swiss Group for Clinical Cancer Research

Completed

SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience

Prostate Cancer | Prostate Cancer Recurrent | Lymph Node Metastases

Switzerland
Price Vision Group
Cornea Research Foundation of America

Terminated

Cross Linking for Treatment of Corneal Infection

Infectious Keratitis

United States
Hellenic Oncology Research Group
University Hospital of Crete

Unknown

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

CRC

Greece
Kinex Pharmaceuticals Inc.
Atlantic Research Group

Completed

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects With Advanced Malignancies

Solid Tumor

United States
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer

Breast Cancer

Greece
Hoag Memorial Hospital Presbyterian
Cancer Biotherapy Research Group

Withdrawn

Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma

Lymphoma

United States
Hoag Memorial Hospital Presbyterian
Cancer Biotherapy Research Group

Withdrawn

Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphoma

Lymphoma

United States
Hoag Memorial Hospital Presbyterian
Cancer Biotherapy Research Group

Withdrawn

Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma

Lymphoma

United States
Hoag Memorial Hospital Presbyterian
Cancer Biotherapy Research Group

Withdrawn

Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Vinorelbine Metronomic Plus Bevacizumab as Salvage Therapy for Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients

Breast Cancer

Greece
Hellenic Oncology Research Group
University Hospital of Crete

Completed

Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer

Gastric Cancer

Greece

Clinical Trials Sponsored by Ovation Research Group

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations